Showing results (461-470 of 688) with videos related to

Sort By:
Pageof 69
Zhonghua Yi Xue Za Zhi|October 31, 2013
[Effects of allitridi capsules on endothelial function and clinical prognosis after percutaneous coronary intervention in coronary artery disease patients with diabetes mellitus]Xiao-min Nie, Ying-xin Zhao, Dong-mei Shi, et al.
Journal of Translational Medicine|July 3, 2014
Non-traditional CD4+CD25-CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantationXiao-su Zhao, Xu-hua Wang, Xiang-yu Zhao, et al.
BMC Pregnancy and Childbirth|December 15, 2020
Maternal postpartum feeding anxiety was associated with infant feeding practices: results from the mother-infant cohort study of ChinaJing Sun, Yimin Zhu, Yongjin Li, et al.
BMC Genomics|December 16, 2021
A high-continuity and annotated tomato reference genomeXiao Su, Baoan Wang, Xiaolin Geng, et al.
Open Biology|September 23, 2016
Exploring the active site of the Streptococcus pneumoniae topoisomerase IV-DNA cleavage complex with novel 7,8-bridged fluoroquinolonesIvan Laponogov, Xiao-Su Pan, Dennis A Veselkov, et al.
Molecular Medicine Reports|August 3, 2017
LncRNA H19 regulates ID2 expression through competitive binding to hsa-miR-19a/b in acute myelocytic leukemiaTong-Feng Zhao, Hui-Zhen Jia, Zhen-Zhen Zhang, et al.
Plant Molecular Biology|August 13, 2013
Interactions between soybean ABA receptors and type 2C protein phosphatasesGe Bai, Da-Hai Yang, Yang Zhao, et al.
Frontiers in Cardiovascular Medicine|November 29, 2023
Comparison of perventricular and percutaneous ultrasound-guided device closure of perimembranous ventricular septal defectsLiu Liu Huang, Mai Chen, De Cai Zeng, et al.
Brain Research|January 17, 2017
Electroacupuncture pretreatment attenuates spinal cord ischemia-reperfusion injury via inhibition of high-mobility group box 1 production in a LXA4 receptor-dependent mannerXiao-Ling Zhu, Xin Chen, Wei Wang, et al.
Leukemia & Lymphoma|October 14, 2016
Concordant optimal molecular and cytogenetic responses at both 3 and 6 months predict a higher probability of MR4.5 achievement in patients with chronic myeloid leukemia treated with imatinibYa-Zhen Qin, Qian Jiang, Yue-Yun Lai, et al.
Pageof 69